Corteva Inc

Corteva, Inc. is a global provider of seed and crop protection solutions focused on the agriculture industry and contributing to food supply. The firm operates through the following segments: Seed and Crop Protection. The Seed segment is engaged in the developing and supplying of advanced germplasm and traits that produce yield for farms. The Crop Protection segment is involved in offering the global agricultural input industry with products that protect against weeds, insects, other pests, and diseases, and that improve overall crop health both above and below ground via nitrogen management and seed-applied technologies. The company was founded in 1802 and is headquartered in Indianapolis, IN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Corteva Inc reports robust 2022 performance and targets growth

Corteva Inc's strong 2022 performance and strategic acquisitions position it well for growth.
Challenges like lower Crop Protection volumes and cost headwinds are being addressed proactively.
Opportunities lie in new product growth, market assumptions for 2023, and achieving long-term targets.
Overall, Corteva Inc remains focused on innovation, margin expansion, and delivering value to shareholders.

Corteva excels in Q1, raises guidance amid market challenges

Corteva's Q1 performance reflects strong growth and margin expansion, with raised full-year guidance signaling confidence in future prospects.
Challenges like pricing headwinds and volume declines in certain regions are being addressed strategically, with opportunities in frontier markets and value creation initiatives.
Overall, Corteva's strategic choices, market share gains, and product innovation position the company well for continued growth and differentiation in the industry.
Investors should monitor Corteva's progress in addressing challenges and capitalizing on opportunities to achieve its ambitious 2025 targets.

Corteva reports growth in Q2 2023 despite challenges ahead

Corteva's Q2 2023 showed growth in seed business but challenges in Crop Protection, leading to adjusted guidance for the year.
Confidence in 2025 financial targets remains strong, with optimism for growth and margin expansion in 2024 driven by new products and cost efficiencies.
Market pressures and customer adjustments impacted earnings cadence, with opportunities seen in gene editing, seed pricing, and future growth drivers.
Improvements expected in free cash flow conversion, destocking challenges, and detailed plans for 2024 growth drivers and financial targets.

Corteva Inc reports robust Q3 performance, eyes growth opportunities

Corteva Inc's Q3 2023 earnings call showcased strong performance and strategic focus on margin expansion and value creation. Despite challenges in destocking and cash flow shortfalls, the company remains optimistic about global demand, margin growth, and operational efficiencies. Corteva's proactive approach to optimizing operations and product portfolio positions it for growth and shareholder returns.

Corteva Inc reports solid 2023 performance amidst Latin America challenges

Corteva's 2023 performance met expectations with strong EBITDA growth and margin expansion.
Challenges in Latin America, especially Brazil, were offset by promising long-term growth opportunities.
The company's strategic focus on high-value products and services positions it well against generic competition.
Overall, Corteva remains committed to providing value through technology and service to farmers.

Corteva Inc meets Q1 expectations, focuses on Enlist technology growth

Corteva Inc's Q1 2024 performance met expectations, with a focus on Enlist technology and biologicals driving growth.
Challenges include volume growth issues in Crop Protection and cost increases in Seed business.
Opportunities lie in new product focus, pricing strategy, and market improvements anticipated in the second half.
Overall, Corteva remains competitive, with a strong financial framework for 2025 and a commitment to engaging investors.

Corteva Inc meets Q3 expectations, eyes record 2025 demand

Corteva's Q3 performance aligned with expectations, emphasizing cost savings and future earnings growth prospects for 2025.
Strategic leadership changes and market assumptions signal a proactive approach to capitalize on record demand and drive business performance.
Challenges include sales declines, cost management, and product performance, while opportunities exist in innovation, investor engagement, and market optimization.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Corteva, Inc. engages in the provision of seed and crop protection solutions, which engages in the agriculture industry and food supply. It operates through the Seed and Crop Protection segments. The Seed segment involves the development and supply of advanced germplasm and traits that produce yield for farms. The Crop Protection segment includes the global agricultural input industry with products for weeds, insects, other pests, and diseases protection, through nitrogen management and seed-applied technologies. The company was founded in 1802 and is headquartered in Indianapolis, IN.

Corteva has outperformed the S&P 500 in the past five years, showcasing the benefits of the 2019 reorganization strategy. Despite its achievements, Corteva's market valuation still lags behind peers like Monsanto prior to their privatization, indicating potential for investor gains. Corteva's robust IP portfolio and strategic acquisitions, including the recent purchase of Stoller, underline its commitment to sustainable agricultural solutions.

Corteva's Strategic Ascend Post DowDuPont Split: Bridging Valuation Gaps

AbbVie

AutoZone

Core Laboratories Inc

Compass Minerals

Estee Lauder

Etsy

Gilead Sciences

Honeywell

Hershey

International Flavors & Fragrances

Johnson & Johnson

Kenvue

McDonald's

MarketAxess Holdings

Motorola Solutions

NIKE

O'Reilly Automotive

Pfizer

Polaris

Philip Morris

Raytheon Technologies

Starbucks

Sysco

Teradyne

We share the heat map of the most investable candidates that may be worth your time for further analysis.

U.S. Wide-Moat Stocks On Sale - The March 2024 Heat Map

NEW YORK--(BUSINESS WIRE)--Ducera Partners LLC, a leading investment bank, today announced that its venture capital investment platform, Ducera Growth Ventures (“Ducera Growth”) has established a strategic collaboration with Corteva Catalyst, a new platform launched by Corteva (NYSE: CTVA) which is designed to identify innovative companies for potential investment or strategic partnership. Ducera Growth Ventures combines investment banking expertise and advanced methodologies, including its pro.

Ducera Growth Ventures Announces Strategic Collaboration with Corteva Catalyst

New Investment and Partnership Platform Will Accelerate Next Generation Ag-tech Innovation   INDIANAPOLIS , March 19, 2024 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) today announced the launch of Corteva Catalyst, a new investment and partnership platform focused on accessing and bringing to market agricultural innovations that advance the company's R&D priorities and drive value creation. Corteva Catalyst will partner with entrepreneurs and innovators to accelerate the development of early-stage, disruptive technologies that enable farmers to sustainably produce more food and feed.

Corteva Launches Corteva Catalyst

INDIANAPOLIS , March 13, 2024 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) today announced it will release its first quarter 2024 earnings on Wednesday, May 1, 2024, after the stock market close via press release and its website. The earnings will be presented in a live webcast on Thursday, May 2, 2024, at 9:00 a.m.

Corteva Announces Dates for First Quarter 2024 Earnings Release and Webcast

Huntington Ingalls Industries

Target

As of March 1, virtually all S&P 500 companies had already reported earnings. Approximately 73% beat the earnings estimates, leaving investors with plenty of top stock superstars to choose from that blew through Wall Street's expectations.

Earnings Crushers: Unveiling Q4's 3 Top Stock Superstars

Corteva, Inc. added to "First Call" Model Portfolio because signals are indicating to us that analysts are recommending buying the stock. Seeking Alpha articles support our improving SID signal, with recent Buy ratings. Chart shows “golden cross” price breakout above long-term downtrend, and insider buying is pointing to further improvements.

Added Corteva To Our Model Portfolio (Technical Analysis)

Evogene

REHOVOT, Israel , March 6, 2024 /PRNewswire/ -- AgPlenus Ltd., a global leader in designing and developing novel sustainable crop protection products and a subsidiary of Evogene Ltd.

AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicides

Corteva, Inc. (CTVA) Bank of America Securities 2024 Global Agriculture & Materials Conference (Transcript)

The payment completes the $5M advance payment received under the licensing agreement for bio-fungicide product candidates REHOVOT, Israel , Feb. 28, 2024 /PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company that develops microbiome-based, computational-driven bio-stimulant and bio-pesticide novel products, and a subsidiary of Evogene Ltd.

Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement Requirements

Register to attend live webcast INDIANAPOLIS , Feb. 22, 2024 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) announces that Chief Executive Officer, Chuck Magro, and Executive Vice President and Chief Financial Officer, Dave Anderson, will speak at the Bank of America Securities 2024 Global Agriculture & Materials Conference at 9:10 a.m. Eastern Time on Wednesday, February 28, 2024.

Corteva to Participate in Bank of America Securities 2024 Global Agriculture & Materials Conference, February 28

Alico

Dole

The Agriculture - Operations industry participants have been impacted by commodity price inflation, reduced export projections and higher costs. Companies like CTVA, DOLE and ALCO stand to gain on solid product portfolios and innovation plans.

3 Agriculture Operations Stocks on the Radar as Inflation Hits Profits

Agilent Technologies

Biogen

Bristol-Myers

C.H. Robinson Worldwide

Comcast

Campbell Soup

Hilton Worldwide Holdings

Harley-Davidson

InterContinental Hotels Group

Lockheed Martin

Marriott

Altria

Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating).

U.S. Wide-Moat Stocks On Sale - The February 2024 Heat Map

Corteva, Inc. (CTVA) Q4 2023 Earnings Call Transcript

While the top- and bottom-line numbers for Corteva, Inc. (CTVA) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Corteva, Inc. (CTVA) Reports Q4 Earnings: What Key Metrics Have to Say

Full-year net sales and earnings demonstrates solid execution and strength of portfolio 2024 guidance3 reflects continued operating EBITDA 1 and margin growth INDIANAPOLIS , Jan. 31, 2024 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) ("Corteva" or the "Company") today reported financial results for the fourth quarter and full-year ended December 31, 2023. 4Q 2023 Results Overview Net Sales Loss from Cont.

Corteva Reports Fourth Quarter and Full-Year 2023 Results, Provides 2024 Guidance

Get a deeper insight into the potential performance of Corteva, Inc. (CTVA) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Unveiling Corteva, Inc. (CTVA) Q4 Outlook: Wall Street Estimates for Key Metrics

Investors interested in Agriculture - Operations stocks are likely familiar with Dole (DOLE) and Corteva, Inc. (CTVA). But which of these two companies is the best option for those looking for undervalued stocks?

DOLE or CTVA: Which Is the Better Value Stock Right Now?

Archer-Daniels-Midland Company

Bunge Global SA

The agricultural commodities sector was one of the hardest hit in recent years, thanks to the Russian invasion of Ukraine. Russia and Ukraine, the two largest wheat exporters, and their conflict disrupted the global food supply chain.

The 3 Best Agriculture Stocks to Buy in January 2024

Ambev

EPAM Systems

Franco-Nevada C

Alphabet

Old Dominion Freight Line

Tradeweb Markets

Investors have been preoccupied with interest rates over the past year. The Federal Reserve raised interest rates at its fastest rate in many years.

7 Steadfast Stocks That Are Unaffected by Interest Rate Changes

Disney

Emerson Electric

Otis Worldwide

PepsiCo

Ross Stores

U.S. Wide-Moat Stocks On Sale - The January 2024 Heat Map

Aflac

Cummins

CVS Health

Dominion Energy

Deere & Company

Discover

Dow Inc

eBay

Con Ed

Elevance Health Inc

Eaton

Fortune Brands Innovations Inc

FirstEnergy

W.W. Grainger

Intel

Nordstrom

Jackson Financial

KeyCorp

Kraft Heinz

In December, we (my wife and I) received a dividend income total of $10,193.04. Crossed the $10k threshold, again. Vanguard's High Dividend Yield ETF, which we have been buying for 3.5 years, literally has paid immense dividends.

Dividend Income Summary: Lanny's December 2023 Summary

UPL to acquire Corteva Agriscience's global mancozeb fungicide business outside of China, Japan, South Korea and EU member countries Mancozeb is a highly effective protective fungicide used to prevent plant diseases across a range of crops LONDON , Jan. 9, 2024 /PRNewswire/ -- UPL Ltd. (NSE: UPL & BSE: 512070 LSE: UPLL) ('UPL'), the global provider of sustainable agricultural solutions, today announces the planned acquisition of Corteva Agriscience's solo mancozeb global fungicide business outside of China, Japan, South Korea, and EU member countries.

UPL To Strengthen Fungicide Portfolio with Planned Acquisition of Corteva's Mancozeb Business

Investors interested in stocks from the Agriculture - Operations sector have probably already heard of Dole (DOLE) and Corteva, Inc. (CTVA). But which of these two companies is the best option for those looking for undervalued stocks?

DOLE vs. CTVA: Which Stock Is the Better Value Option?

Neste Oyj

These three agri-tech stocks will be boosted by the field's rapid growth.

Agriculture Advancements: 3 Stocks Cultivating Growth in Agri-Tech

News for Corteva Inc Stock (CTVA)